Head-to-head · WeighScore
altRX vs Voxy
The verdict
altRX takes it — 71.4/100 to 62.1/100.
altRX grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. altRX is a dual-modality telehealth platform offering compounded GLP-1s plus all four brand-name FDA-approved options — Mounjaro, Ozempic, Wegovy, and Zepbound — the most comprehensive brand-name lineup in…
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | altRX | Voxy |
|---|---|---|
| WeighScore | 71.4/100 | 62.1/100 |
| Grade | C | C |
| Scorecard rank | #93 | #280 |
| Semaglutide | $149/mo (starting dose, compounded) | $179/mo (compounded) |
| Tirzepatide | $249/mo (starting dose, compounded) | $299/mo (compounded) |
| Coverage | Coverage not published | Coverage not published |
| Brand-name access | Yes | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Graded #93 · C
Strengths
- Offers all four brand-name FDA-approved GLP-1s (Mounjaro, Ozempic, Wegovy, Zepbound) — the most comprehensive brand-name access we've reviewed
- LegitScript Certified with a publicly verifiable seal
- Publishes the FDA compounded-medication disclaimer
- Transparent pricing across all six product tiers (compounded plus four brand-name)
- All-inclusive pricing — consult, prescription, and shipping with no hidden fees
Where it loses points
- States-served list not disclosed
- 503A/503B pharmacy partner not named (only 'multiple USA-certified pharmacies')
- 503A vs 503B designation not specified
- No named medical director
- Corporate physical address not disclosed
Graded #280 · C
Strengths
- Names both its compounding pharmacy (VialsRX, Houston TX) and its prescribing medical group (Arora Health & Aesthetics) — most name neither
- Publishes the full price ladder for both drugs across 1-, 3-, 6- and 12-month terms before you start the assessment
- One price covers the provider visit, medication, injection supplies, shipping and monthly check-ins — no separate membership fee
- True month-to-month option at $179 semaglutide / $299 tirzepatide with no commitment required
- Free assessment with no charge to see if you qualify, and no labs required to start
Where it loses points
- No terms of service anywhere on the site — /terms, /terms-of-service and /terms-of-use all return 404
- No refund policy published; the only stated commitment language is 'cancel anytime'
- Advertised 'Starting at $129/mo' is the 12-month prepay rate — month-to-month is $179 semaglutide and $299 tirzepatide
- No public list of states served; availability depends on where affiliated providers are licensed
- The prescribing nurse practitioner is not named — 'provider details available during your consultation'
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.